Clinical Trials Logo

Deafness clinical trials

View clinical trials related to Deafness.

Filter by:

NCT ID: NCT05379231 Completed - Unilateral Deafness Clinical Trials

Evaluation of BiCROS Fitting Benefits

Start date: July 11, 2022
Phase: N/A
Study type: Interventional

23 candidates for BiCROS hearing aids will be recruited and fitted with a hearing aid and a CROS device. Following a real-world trial, each participant will be tested on a range of outcome measures including speech recognition in noise, ratings of listening effort, and ratings of preference.

NCT ID: NCT05377359 Recruiting - Hearing Loss Clinical Trials

Lab Evaluation of Novel Hearing Aid Coupling Method

Start date: March 1, 2023
Phase: N/A
Study type: Interventional

Evaluation of different hearing aid coupling methods including two states of a novel coupling method and two traditional coupling methods.

NCT ID: NCT05356221 Recruiting - Hearing Loss Clinical Trials

Cross-sectional Evaluation of the Subjective Performance and Satisfaction With Ponto Sound Processors

BC112
Start date: April 11, 2022
Phase:
Study type: Observational

The study is a non-interventional, observational, cross-sectional, study on users of Ponto sound processors. The purpose of this study is to evaluate subjectively assessed hearing performance and satisfaction with Oticon Medical's sound processors fitted with the Genie Medical fitting software.

NCT ID: NCT05343026 Not yet recruiting - Clinical trials for Tinnitus, Subjective

Efficacy of Hearing-aid Treatment for Patients With Tinnitus and Co-existing Hearing Loss

Start date: July 1, 2022
Phase: N/A
Study type: Interventional

Considering the extent to which HAs play a role in sound perception and residual hearing preservation among patients with tinnitus and co-existing HL remains a lack of compelling extensive evidence, investigators designed this single-blind, 6-months randomized, controlled trial with two parallel groups. One is the HA treatment group, and the other is the waiting list control (WLC) group which receives no interventions during this period.

NCT ID: NCT05337748 Completed - Hearing Loss Clinical Trials

Clinical Validation of the Lexie Lumen Hearing Aid

Start date: April 11, 2022
Phase: N/A
Study type: Interventional

More than half a billion people globally have hearing loss. Most hearing loss is sensorineural, meaning that the hearing loss is irreversible and requires rehabilitation. The majority of people with hearing loss have mild to moderate degrees, for which the most effective treatment options are hearing aids. Over the past few years, there have been many developments in hearing technology and the service delivery models in which they are supplied. Traditional hearing care models include several visits to a qualified hearing professional who must both perform diagnostics and prescribe hearing aids, which in the past has been the only way to obtain hearing aids. However, newer developments include forms of self-fitting hearing aids that enable a user to perform threshold measurements to determine the degree of hearing loss and automatically program and fine-tune hearing aids. These devices are now becoming available as direct-to-consumer (DTC) or over-the-counter (OTC) hearing aids. Furthermore, alternative care models have been suggested to bolster access and uptake of assistive technology for hearing loss. Regulations on DTC and OTC hearing aids are starting to come into effect. In 2017, the FDA Reauthorization Act of 2016 directed the FDA to create a category for OTC hearing aids for adults with perceived mild-to-moderate hearing loss. In October 2021, the FDA formally proposed a rule to establish the OTC hearing aid category as part of this process. These changes in regulations would mean that soon, many of these self-fitting devices will become available. In response to these changes in service delivery models, the hearX group recently developed the Lexie Lumen hearing aids that can perform in-situ hearing threshold estimations and automatically prescribe hearing aid gain settings that closely approximate the gold-standard NAL-NL2 fitting prescription. This study aims to evaluate whether the performance of the novel Lexie self-test and self-fitting hearing aid is equivalent to the same hearing aid programmed professionally by an audiologist using a professionally obtained audiogram.

NCT ID: NCT05331404 Recruiting - Hearing Loss Clinical Trials

Evaluation of Hearing Aids Rehabilitation Within Age-related Hearing Loss Population.

AGEHEAR
Start date: June 2, 2022
Phase: N/A
Study type: Interventional

Hearing aids restore efficiently some auditory functions in age-related hearing loss (ARHL or presbycusis) providing to the elderly an access to oral communication and a return to social life. However, a most of the assessments of their efficacy focus on speech recognition. Spatial hearing and localization are anothers important auditory functions merely evaluated. The purpose of this study is to evaluate the hearing aids benefits for spatial hearing.

NCT ID: NCT05330585 Enrolling by invitation - Hearing Loss Clinical Trials

fNIRs, Listening Effort, and Speech Intelligibility

Start date: May 3, 2022
Phase: N/A
Study type: Interventional

The purpose of the current study is to measure oxygenation in the PFC using fNIRS in a sample of older adults with hearing loss. Adults with hearing loss will be asked to repeat the final word from low-context sentences in noise at two SNRs; a hard SNR (individually-measured SNR-50), and an easy SNR (SNR-50 + 10 dB) both without and with hearing aids set to a directional mode. The procedure will be a within-subject repeated measures. Stimuli will be randomized.

NCT ID: NCT05329207 Not yet recruiting - Health Promotion Clinical Trials

Effects of Web-Based Adolescent Health Promotion Program in Hearing Impaired Adolescents

ASGE-FABES
Start date: April 18, 2022
Phase: N/A
Study type: Interventional

Our research is to evaluate the effect and applicability of the adolescent health promotion program, which includes multiple behavioral interventions, on physical activity, nutrition and mental health of hearing impaired adolescents living in the community.

NCT ID: NCT05318417 Recruiting - Clinical trials for Hearing Loss, Unilateral

Investigation to Evaluate the Safety and Effectiveness of Cochlear Implantation in Children and Adults With Unilateral Hearing Loss/Single-sided Deafness

PAS-SSD
Start date: August 19, 2022
Phase: N/A
Study type: Interventional

The aim of the study is to assess the continued efficacy and safety of cochlear implantation in participants aged 5 years and above with Unilateral Hearing Loss (UHL)/Single Sided Deafness (SSD) supporting a change indication for use.

NCT ID: NCT05307952 Recruiting - Deafness, Bilateral Clinical Trials

Auditory Diagnostics and Error-based Treatment

AuDiET
Start date: May 30, 2022
Phase: N/A
Study type: Interventional

The main objective of this study is to assess the effectiveness of an integrated program of fitting and training interventions aimed at reducing unexpected variability and addressing the specific error patterns of each recipient. The participants will undergo 1 visit lasting approximately 2 hours at the Radboud university medical center's ENT department, where they will undergo a series of diagnostic tests. Some of the participants will also be asked to self-administer additional tests using a Windows tablet. Based on the outcomes of speech recognition tests in quiet at the first visit, the participants will be called for follow-up interventions concerning both the fitting of their CI and personalized auditory training based on their personal error patterns. These interventions will take place over the course of approximately 5 months and will be made up of three follow-up visits and a period of self-administered training through a mobile application on a tablet. One final follow-up visit will check whether any changes from the interventions are retained after four weeks.